Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/20
End: 10/08/23
Due: 10/08/24
Phase: N/A
Priority: Normal
Start: 11/11/22
End: 07/29/24
Due: 07/29/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers | NCT05496205 | iN Therapeutics Co., Ltd. | user2@example.com | None | 2020-09-30 | 2023-10-08 | 2024-10-08 | - | - | 2025-07-14 |
| A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients. | NCT06218784 | iN Therapeutics Co., Ltd. | user2@example.com | None | 2022-11-11 | 2024-07-29 | 2025-07-29 | - | - | 2025-07-14 |